Post by
sebraz on Sep 24, 2021 7:01am
Rising Costs irrelevant to short term stock price..
Although interesting for the DME industry, not short-term relevant to Quipt's share price.
Quipt will only report next quarterly performance in January and will not likely discuss inflationary pressures until then.
Rising costs, inflation etc psychologically do not matter to investors in quipt. Our catalysts will continue to be announcement of acquisitions. These are the only things that matter for the next few months.
Comment by
besttobe on Sep 24, 2021 11:56am
So true. Smart money/wise investors totally ignore headwinds that effect a stock they are invested in. Makes sense.
Comment by
lscfa on Sep 25, 2021 12:46pm
The industry is lobbying for higher reimbursement rates and all the proof they need is the failed competitive bidding round which showed many items are grossly under-reimbursed..... https://www.hmenews.com/article/cms-shares-bid-pricing-for-round-2021